These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31603967)

  • 21. Eyelash growth induced by topical prostaglandin analogues, bimatoprost, tafluprost, travoprost, and latanoprost in rabbits.
    Giannico AT; Lima L; Russ HH; Montiani-Ferreira F
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):817-20. PubMed ID: 23981234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired hypertrichosis of the periorbital area and malar cheek.
    Purvis CG; Bandino JP; Elston DM
    Cutis; 2019 Apr; 103(4):E20-E21. PubMed ID: 31116825
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term safety and efficacy of bimatoprost solution 0ยท03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: a randomized controlled trial.
    Glaser DA; Hossain P; Perkins W; Griffiths T; Ahluwalia G; Weng E; Beddingfield FC
    Br J Dermatol; 2015; 172(5):1384-94. PubMed ID: 25296533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.
    Fagien S; Walt JG; Carruthers J; Cox SE; Wirta D; Weng E; Beddingfield FC
    Aesthet Surg J; 2013 Aug; 33(6):789-98. PubMed ID: 23873891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bimatoprost (0.03%)-induced accommodative spasm and pseudomyopia.
    Padhy D; Rao A
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26598527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost.
    Herane MI; Urbina F
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):644-5. PubMed ID: 15324422
    [No Abstract]   [Full Text] [Related]  

  • 27. A prospective right-left comparative study to evaluate the efficacy and tolerability of combination of NB-UVB and topical bimatoprost 0.03% eye drops versus NB-UVB given alone in patients of vitiligo vulgaris.
    Sharma S; Parsad D; Bhattacharjee R; Muthu SK
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e330-e331. PubMed ID: 29444382
    [No Abstract]   [Full Text] [Related]  

  • 28. Periorbital changes associated with topical bimatoprost.
    Filippopoulos T; Paula JS; Torun N; Hatton MP; Pasquale LR; Grosskreutz CL
    Ophthalmic Plast Reconstr Surg; 2008; 24(4):302-7. PubMed ID: 18645437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys.
    Prota G; Vincensi MR; Napolitano A; Selen G; Stjernschantz J
    Pigment Cell Res; 2000 Jun; 13(3):147-50. PubMed ID: 10885672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased iridial pigmentation in Chinese eyes after use of travoprost 0.004%.
    Huang P; Zhong Z; Wu L; Liu W
    J Glaucoma; 2009 Feb; 18(2):153-6. PubMed ID: 19225354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deepening of lid sulcus from topical bimatoprost therapy.
    Peplinski LS; Albiani Smith K
    Optom Vis Sci; 2004 Aug; 81(8):574-7. PubMed ID: 15300114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical bimatoprost 0.03% and iatrogenic eyelid and orbital lipodystrophy.
    Sira M; Verity DH; Malhotra R
    Aesthet Surg J; 2012 Sep; 32(7):822-4. PubMed ID: 22942109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertrichosis of vellus hairs of the malar region after unilateral treatment with bimatoprost.
    Hart J; Shafranov G
    Am J Ophthalmol; 2004 Apr; 137(4):756-7. PubMed ID: 15059720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin-induced iris color darkening. An experimental model.
    Zhan GL; Toris CB; Camras CB; Wang YL; Bito LZ
    Arch Ophthalmol; 1998 Aug; 116(8):1065-8. PubMed ID: 9715687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eyelash growth: a beneficial side effect of prostaglandin analogues.
    Bikowski J; Lau EG; Jacob SE
    Cutis; 2010 Apr; 85(4):187-8. PubMed ID: 20486457
    [No Abstract]   [Full Text] [Related]  

  • 36. Commentary: From serendipity to pilot study and then pivotal trial: bimatoprost topical for eyelash growth.
    Cohen JL
    Dermatol Surg; 2010 May; 36(5):650-1. PubMed ID: 20384740
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hyperpigmentosis and hypertrichosis of the eyelids after use of bimatoprost eye drops].
    Modschiedler K; von den Driesch P; Paus R
    J Dtsch Dermatol Ges; 2005 Apr; 3(4):276-7. PubMed ID: 16370476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth.
    Yoelin S; Walt JG; Earl M
    Dermatol Surg; 2010 May; 36(5):638-49. PubMed ID: 20384751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Betaxolol-associated hyperpigmentation of the fingers in a patient with unrelated contact dermatitis.
    Adams DR; Marks JG
    Am J Contact Dermat; 1997 Sep; 8(3):183-4. PubMed ID: 9249294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Safety of Bimatoprost 0.01% for the Treatment of Eyebrow Hypotrichosis: A Randomized, Double-Blind, Vehicle-Controlled Study.
    Suchonwanit P; Chanasumon N; Sriphojanart T
    Dermatol Surg; 2019 Dec; 45(12):1549-1556. PubMed ID: 30913051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.